BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1699689)

  • 1. The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children.
    Loche S; Pintus S; Cella SG; Boghen M; Vannelli S; Benso L; Müller EE; Corda R; Pintor C
    Clin Endocrinol (Oxf); 1990 Aug; 33(2):187-92. PubMed ID: 1699689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children.
    Loche S; Vista N; Ghigo E; Vannelli S; Arvat E; Benso L; Corda R; Cella SG; Müller EE; Pintor C
    Pediatr Res; 1990 Apr; 27(4 Pt 1):405-7. PubMed ID: 1692988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children.
    Loche S; Pintor C; Cappa M; Ghigo E; Puggioni R; Locatelli V; Müller EE
    Acta Endocrinol (Copenh); 1989 May; 120(5):624-8. PubMed ID: 2499149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galanin reinstates the growth hormone response to repeated growth hormone-releasing hormone administration in man.
    Arvat E; Ghigo E; Nicolosi M; Boffano GM; Bellone J; Yin-Zhang W; Mazza E; Camanni F
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):347-50. PubMed ID: 1385023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of atenolol on the growth hormone response to growth hormone-releasing hormone in obese children.
    Loche S; Pintus S; Carta D; Muntoni AC; Congiu G; Civolani P; Pintor C
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):124-7. PubMed ID: 1311892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment.
    Giustina A; Girelli A; Bossoni S; Legati F; Schettino M; Wehrenberg WB
    Metabolism; 1992 May; 41(5):548-51. PubMed ID: 1375312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women.
    Giustina A; Gastaldi C; Bugari G; Chiesa L; Loda G; Tironi C; Negro-Vilar A
    Metabolism; 1995 Aug; 44(8):1028-32. PubMed ID: 7543651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay.
    Sartorio A; Conti A; Monzani M; Faglia G
    J Endocrinol Invest; 1995 Feb; 18(2):109-12. PubMed ID: 7543124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children.
    Ghigo E; Mazza E; Corrias A; Imperiale E; Goffi S; Arvat E; Bellone J; De Sanctis C; Müller EE; Camanni F
    Metabolism; 1989 Jul; 38(7):631-3. PubMed ID: 2500577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects.
    Lee EJ; Nam SY; Kim KR; Lee HC; Cho JH; Nam MS; Song YD; Lim SK; Huh KB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2495-8. PubMed ID: 7629249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of sex on the increase of GH induced by galanin, alone or in combination with GHRH with or without pyridostigmine in pubescent subjects].
    Guzzaloni G; Grugni G; Ardizzi A; Moro D; Calò G; Morabito F
    Minerva Endocrinol; 1996 Jun; 21(2):53-7. PubMed ID: 9026681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
    Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of salbutamol and galanin on both basal and growth hormone releasing hormone-stimulated growth hormone secretion in humans.
    Arvat E; Ramunni J; Gianotti L; Di Vito L; Maccario M; Camanni F; Ghigo E
    J Endocrinol Invest; 1995 May; 18(5):324-8. PubMed ID: 7594218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
    Cordido F; Peñalva A; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man.
    Ghigo E; Maccario M; Arvat E; Valetto MR; Valente F; Nicolosi M; Mazza E; Martina V; Cocchi D; Camanni F
    Metabolism; 1992 Jan; 41(1):85-9. PubMed ID: 1371576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa.
    De Marinis L; Mancini A; Valle D; Bianchi A; Gentilella R; Milardi D; Mascadri C; Giustina A
    Metabolism; 2000 Feb; 49(2):155-9. PubMed ID: 10690937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
    Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation and neuroregulatory control of growth hormone secretion.
    Ogilvy-Stuart AL; Wallace WH; Shalet SM
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):163-8. PubMed ID: 7923820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.